Hexa Research Inc.

Industry Research,Custom Research & Consulting

Peptide Therapeutics Market Analysis, Market Size, Share,

Regional Outlook, Industry Trends, Competitive Strategies
And Segment Forecast From 2012 To 2020

Industry Insights
Peptide therapeutics market is expected to grow over the forecast period owing to the increasing
prevalence of cancer and other various metabolic diseases. The other growth drivers of this market are
introduction of technological advancements such as hybrid method of synthesis of peptides, lifestyle
induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing
population and awareness.
Peptides are referred as amide bonds which are linked with small chains of amino acid monomers.
Peptides differ from protein on the basis of size. The presence of amino acids in peptides is less than 55
molecules. Peptides crunch themselves to some imitate such as receptor ligands and specific cell surface
receptors. As peptides act on cell membrane, so it helps peptides in treating various diseases.
Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/peptidetherapeutics-industry/

Hexa Research Inc.

Industry Research,Custom Research & Consulting
As the market has a huge potential, thus various biotechnology and pharmaceutical industries are
developing new peptides that can be used for various purposes. So these companies are actively
investing in high R&D activities. Globally, cancer has been a foremost cause of death. As per the recent
report published by WHO, it says that as of 2012, total number of cancer patient increased to 12.9
million and it is expected to be 16.2 million over the forecast period.
Peptide therapeutics market is expected to boost owing to rise in metabolic diseases such as obesity &
diabetes and further with growth in number of cancer patients. Various routes of administration and
technologies in peptides have developed due to continuous R&D. In 2103, parenteral route of peptides
has captured highest revenue share. Parenteral route is one of the conventional routes of
administration. In 2013, long phase peptide synthesis has dominated the technology phase. The market
serves the huge opportunity over the upcoming five years.
Technology Insight
Peptide therapeutics market is segmented on the basis of technology into HPPS, LPPS and SPPS. Among
these SPPS technology held the largest market share in 2013 due to user friendliness and cost effective.
In recent years HPSS technology has generated huge momentum and it is expected to be fastest growing
technology over the forecast period.
Application Insights
Peptide therapeutics market is segmented on the basis of application into metabolic, cancer, CNS and
CVS. In 2013, Peptide therapeutics had occupied most of the market share as it is used for treatment of
cancer. Growing incidences of cancer and awareness is expected to drive the market over the forecast
period.
Request A Sample copy of This Report @ http://www.hexaresearch.com/sample/169
Segment (Route of Administration) Insight
Peptide therapeutics market is segmented on the basis route of administration into oral, parenteral,
mucosal and pulmonary. Among these parenteral routes held the largest market share in 2013, as it is
used for a long time. Over the upcoming five years higher comfort level of patients is expected to drive
the parenteral route.

Hexa Research Inc.

Industry Research,Custom Research & Consulting
Product Insight
Peptide therapeutics market is segmented on the basis product types into generic and innovative.
Among these, innovative peptides held the largest market share in 2013, as it is cost effective as
compared to generic peptides. With the help of technological advancement it is expected to grow over
the forecast period.
Regional Insights
Geographically, the Peptide therapeutics market is studied by segmenting the market into North
America, Europe, Asia Pacific and RoW. North America is dominating the whole market due to high per
capita healthcare expenditure, sophisticated healthcare infrastructure, rising disposable income, various
government or NGOs initiatives and increasing geriatric population. Asia Pacific is expected to witness
lucrative growth rate over the forecast period due to increasing population, government initiatives and
growing economies.
Competitive Insights
The major market players in the Peptide therapeutics market are Bristol-Myers Squibb (BMS), Amylin
Pharmaceuticals LLC, Bachem Holding AG, Roche, Amgen Inc., Peptisyntha, Ipsen, Eli Lilly and Company,
AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Merck & Co., Lonza Inc., Novartis AG,
GlaxoSmithKline (GSK), PolyPeptide Group, Novo-Nordisk A/S, Pfizer Inc., Sanofi, and Teva
Pharmaceuticals.
Table of Contents
Chapter 1 Executive Summary
1.1 Peptide Therapeutics Industry Summary & Critical Success Factors (CSFs)
Chapter 2 Peptide Therapeutics Industry Outlook
2.1 Market Segmentation
2.2 Market Size and Growth Prospects
2.3 Peptide Therapeutics Value Chain Analysis
2.4 Peptide Therapeutics Market Dynamics
2.5 Key Opportunities Prioritized
2.6 Industry Analysis - Porter's

Hexa Research Inc.

Industry Research,Custom Research & Consulting
2.7 Peptide Therapeutics - Company Market Share Analysis
2.8 Peptide Therapeutics - PESTEL Analysis
Chapter 3 Peptide TherapeuticsTechnologyOutlook
3.1 Solid Phase Peptide Synthesis (SPPS)
3.2 Liquid Phase Peptide Synthesis (LPPS)
3.3 Hybrid Phase Peptide Synthesis (HPSS)
Browse All Healthcare IT Industry Research Related Reports @
http://www.hexaresearch.com/research-category/healthcare-it-industry/
Chapter 4 Peptide Therapeutics Application Outlook
4.1 Cancer
4.2 Metabolic
4.3 Cardiovascular
4.4 Dermatology
4.5 Anti-infection
4.6 Gastro Intestinal
4.7Renal
4.8 Respiratory
Chapter 5 Peptide Therapeutics Route Outlook
5.1 Parenteral Route
5.2 Oral Route
5.3 Pulmonary Route
5.4 Mucosal Route
5.5 Other Routes (Intradermal & Nasal)
Chapter 6 Peptide Therapeutics Product Outlook
6.1 Innovative
6.2 Generic
Chapter 7 Peptide Therapeutics Regional Outlook
7.1 North America
7.2 Europe
7.3 Asia Pacific

Hexa Research Inc.

Industry Research,Custom Research & Consulting
7.4 RoW
Chapter 8 Competitive Landscape
8.1 Amgen Inc.
8.2 Amylin Pharmaceuticals LLC- Bristol- Myers Squibb (BMS)
8.3 AstraZeneca PLC
8.4 Bachem Holding AG
8.5 Eli Lilly and Company
8.6 GlaxoSmithKline (GSK)
8.7 Ipsen
8.8 Lonza Inc.
Chapter 9 Methodology & Scope
9.1 Research Methodology
9.2 Research Scope & Assumptions
9.3 List of Data Sources
Browse Full Report @ http://www.hexaresearch.com/research-report/peptide-therapeutics-industry/
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - http://www.hexaresearch.com/
Visit our Blogs: http://2015hexaresearchpapers.blogspot.com/